• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.79% Nasdaq Up0.16%

    Enzo Biochem Inc. (ENZ)

    -NYSE
    3.47 Down 0.02(0.57%) Jan 23, 4:02PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingOct 31, 2014Jul 31, 2014Apr 30, 2014Jan 31, 2014
    Total Revenue 24,824   24,907   23,979   22,927  
    Cost of Revenue13,825  13,972  13,583  13,158  
    Gross Profit 10,999   10,935   10,396   9,769  
    Operating Expenses
    Research Development791  643  849  832  
    Selling General and Administrative10,285  10,584  10,605  10,083  
    Non Recurring3,007  2,761  (505)2,408  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,084) (3,053) (553) (3,554)
    Income from Continuing Operations
    Total Other Income/Expenses Net(453)(62)152  35  
    Earnings Before Interest And Taxes(3,606)(3,162)(448)(3,571)
    Interest Expense -   -   -   -  
    Income Before Tax(3,606)(3,162)(448)(3,571)
    Income Tax Expense123  7  7  (5)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(3,729)(3,169)(455)(3,566)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (3,729) (3,169) (455) (3,566)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (3,729) (3,169) (455) (3,566)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.